1. Eur J Med Chem. 2019 Feb 1;163:853-863. doi: 10.1016/j.ejmech.2018.12.022.
Epub  2018 Dec 12.

Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl 
compound bearing a bipyridine-biotin ligand.

Côrte-Real L(1), Karas B(2), Gírio P(3), Moreno A(4), Avecilla F(5), Marques 
F(6), Buckley BT(7), Cooper KR(8), Doherty C(7), Falson P(4), Garcia MH(1), 
Valente A(9).

Author information:
(1)Centro de Química Estrutural, Faculdade de Ciências da Universidade de 
Lisboa, Campo Grande, 1749-016, Lisboa, Portugal.
(2)Environmental and Occupational Health Sciences Institute, Rutgers University, 
170 Frelinghuysen Road, Piscataway, NJ, 08854, USA; Department of Biochemistry 
and Microbiology, Rutgers University, 76 Lipman Drive, New Brunswick, NJ, 08854, 
USA.
(3)Centro de Química Estrutural, Faculdade de Ciências da Universidade de 
Lisboa, Campo Grande, 1749-016, Lisboa, Portugal; Drug Resistance and Membrane 
Proteins Team, Molecular Biology and Structural Biochemistry Laboratory, UMR 
5086 CNRS-UCBL1, IBCP 7 Passage du Vercors, 69 367, Lyon Cedex 07, France.
(4)Drug Resistance and Membrane Proteins Team, Molecular Biology and Structural 
Biochemistry Laboratory, UMR 5086 CNRS-UCBL1, IBCP 7 Passage du Vercors, 69 367, 
Lyon Cedex 07, France.
(5)Grupo Xenomar, Centro de Investigacións Científicas Avanzadas (CICA), 
Departamento de Química, Facultade de Ciencias, Universidade da Coruña, Campus 
de A Coruña, 15071 A, Coruña, Spain.
(6)Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, 
Universidade de Lisboa, Estrada Nacional 10, Km 139.7, 2695-066, Bobadela LRS, 
Portugal.
(7)Environmental and Occupational Health Sciences Institute, Rutgers University, 
170 Frelinghuysen Road, Piscataway, NJ, 08854, USA.
(8)Department of Biochemistry and Microbiology, Rutgers University, 76 Lipman 
Drive, New Brunswick, NJ, 08854, USA.
(9)Centro de Química Estrutural, Faculdade de Ciências da Universidade de 
Lisboa, Campo Grande, 1749-016, Lisboa, Portugal. Electronic address: 
amvalente@fc.ul.pt.

Two new ruthenium complexes, [Ru(η5-Cp)(PPh3)(2,2'-bipy-4,4'-R)]+ with 
R = -CH2OH (Ru1) or dibiotin ester (Ru2) were synthesized and fully 
characterized. Both compounds were tested against two types of breast cancer 
cells (MCF7 and MDA-MB-231), showing better cytotoxicity than cisplatin in the 
same experimental conditions. Since multidrug resistance (MDR) is one of the 
main problems in cancer chemotherapy, we have assessed the potential of these 
compounds to overcome resistance to treatments. Ru2 showed exceptional 
selectivity as P-gp inhibitor, while Ru1 is possibly a substrate. In vivo 
studies in zebrafish showed that Ru2 is well tolerated up to 1.17 mg/L, 
presenting a LC50 of 5.73 mg/L at 5 days post fertilization.

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

DOI: 10.1016/j.ejmech.2018.12.022
PMCID: PMC6345558
PMID: 30579125 [Indexed for MEDLINE]